Nestle has completed the sale of its remaining 52% stake in Alcon, the global eye care business, to Novartis for $28.3b. Nestle acquired Alcon in 1977 for $280m. Over the
Nestle has completed the sale of its remaining 52% stake in Alcon, the global eye care business, to Novartis for $28.3b. Nestle acquired Alcon in 1977 for $280m. Over the